33 related articles for article (PubMed ID: 26486708)
21. Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.
Sucher AJ; Chahine EB; Cogan P; Fete M
Ann Pharmacother; 2015 Sep; 49(9):1046-56. PubMed ID: 26160970
[TBL] [Abstract][Full Text] [Related]
22. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Bonafede ME; Blumer JL
Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
[No Abstract] [Full Text] [Related]
23. Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections.
Skalweit MJ
Drug Des Devel Ther; 2015; 9():2919-25. PubMed ID: 26082619
[TBL] [Abstract][Full Text] [Related]
24. Role of pharmacodynamics in designing dosage regimens for beta-lactams.
Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
Conn Med; 2003 May; 67(5):265-8. PubMed ID: 12802841
[No Abstract] [Full Text] [Related]
25. [Antibiotics: new and old drugs, rational prescription].
de With K; Stocker H; Borde J; Kern WV
Dtsch Med Wochenschr; 2012 Feb; 137(5):186-9. PubMed ID: 22278687
[No Abstract] [Full Text] [Related]
26. [New methods of administration of cephalosporins and aminoglycosides: relations between pharmacokinetics and pharmacodynamics].
Kamnev IuV
Antibiot Khimioter; 1992 Feb; 37(2):44-50. PubMed ID: 1514855
[No Abstract] [Full Text] [Related]
27. [Antibiotic therapy of intra-abdominal infections in the era of multiresistance].
Eckmann C
Chirurg; 2016 Jan; 87(1):26-33. PubMed ID: 26577434
[TBL] [Abstract][Full Text] [Related]
28. Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?
Attivi D; Gibaud S
Ann Pharm Fr; 2014 May; 72(3):146-51. PubMed ID: 24780830
[TBL] [Abstract][Full Text] [Related]
29. Response to Spellberg and Brass.
Solomkin JS; Hershberger E; Eckmann C
Clin Infect Dis; 2016 Feb; 62(4):526. PubMed ID: 26486708
[No Abstract] [Full Text] [Related]
30. Ceftolozane/Tazobactam (Zerbaxa)--a new intravenous antibiotic.
Med Lett Drugs Ther; 2015 Mar; 57(1463):31-3. PubMed ID: 25719997
[No Abstract] [Full Text] [Related]
31. Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections.
Eckmann C; Solomkin J
Expert Opin Pharmacother; 2015 Feb; 16(2):271-80. PubMed ID: 25529765
[TBL] [Abstract][Full Text] [Related]
32. Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
Maseda E; Aguilar L; Gimenez MJ; Gilsanz F
Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1311-24. PubMed ID: 25139127
[TBL] [Abstract][Full Text] [Related]
33. New and Emerging Antibiotics for Complicated Intra-Abdominal Infections.
Durand CR; Alsharhan M; Willett KC
Am J Ther; 2017; 24(6):e763-e769. PubMed ID: 26796653
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
